GALT Competitors & Alternatives
Compare Galectin Therapeutics Inc with similar stocks in the same industry
Biotechnology
GALT
Main Stock$3.37
Tradestie Score
55
Market Cap
$267.77M
Analyst Upside
+226.4%
Top Competitors
224 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$10.73
|
$386.68M | - | 55 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$6.46
|
$382.04M | - | 62 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$13.48
|
$371.64M | - | 61 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$14.89
|
$354.45M | - | 56 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$39.23
|
$353.70M | 410.0 | 38 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.44
|
$350.98M | - | 63 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$3.86
|
$332.96M | - | 59 | Compare |
|
REPL
Replimune Group, Inc.
|
$11.72
|
$328.62M | - | 49 | Compare |
|
EPRX
Eupraxia Pharmaceuticals Inc. Common Stock
|
$7.73
|
$307.12M | - | 61 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$8.37
|
$304.12M | - | 60 | Compare |
More GALT Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2834)
224 stocks in this industry